David R Stevens insider trades: Ampio Pharmaceuticals (AMPE) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 12, 2023 | AMPE | ↑ Buy | 95,000 | $0.22 | $21K | Direct | May 12, 2023 (0d) |
| Jan 9, 2009 | PARD | ↑ Buy | 6,450 | $3.44 | $22K | Direct | Jan 13, 2009 (4d) |
| Jan 15, 2008 | PARD | ↑ Buy | 7,618 | $5.25 | $40K | Direct | Jan 16, 2008 (1d) |
| May 18, 2005 | NERX | ↑ Buy | 34,500 | $0.51 | $18K | Direct | May 23, 2005 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David R Stevens's insider trades
David R Stevens is a director at Ampio Pharmaceuticals (AMPE). Since May 18, 2005, David has reported 4 open-market purchases worth $101K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (29 filings), shares returned to the company (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AMPE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.